Southern Africa — Gus Attridge — South Africa — Johannesburg Stock Exchange — Aspen Pharmacare — Hot News
Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Related
Transaction Capital sells non-core assets in $28.8-million deal
The divestiture, finalized on Nov. 1, is part of Transaction Capital's strategy to streamline operations and focus on core business areas.
Stephen Brookes’ Balwin stake soars above $20 million
Stephen Brookes sees his Balwin Properties stake rise above $20 million amid a rally in the company's shares on the JSE.
Vodacom faces regulatory setback in $790-million Maziv acquisition
Vodacom's Maziv deal blocked by Competition Tribunal. Regulatory hurdles stifle expansion plans.
Pick 'n Pay announces exit from Nigeria amid financial losses
South African retailer offloads stake amid challenging market conditions.
Latest
CI Capital completes $80 million bond issuance, setting record in Egypt’s non-banking sector
The six-tranche bond issuance is underpinned by assets from Tasaheel, which served as the originator of the portfolio.
MTN Uganda posts $637.4 million revenue in 9M 2024
MTN Uganda’s financial success translated into a notable profit increase of 29.6 percent, rising from Ush354.44 billion ($96.87 million) to Ush459.42 billion ($125.58 million).
The 10 biggest donations by Femi Otedola: How he is building a legacy of impact
Otedola’s generosity has touched lives nationwide, with substantial donations spanning education, health, security, and economic empowerment.
Safaricom's CEO Peter Ndegwa earns $1.95 million in 2024 salary
This marks a 19.4 percent decline from last year's earnings of $2.42 million, primarily due to a 31.7 percent drop in the value of share-based awards.